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Abstract
The purpose of this research was to examine (1) the rates of elevated blood glucose > 150
mg/dL in adults without a prior history of diabetes, receiving care for a non-diabetes
related visit to the ED and (2) Emergency Department provider patterns for informing
and referring discharged Emergency Department patients for follow-up of elevated
random blood glucose levels. A descriptive, correlational, cross-sectional design, with
purposive sample was used. Retrospective chart review was done for patients age 18 and
older, treated in two EDs from March 1,2010 through March 22, 2010. Significant
relationships were found between blood glucose level and BMI, previous blood glucose
level >150 mg/dL, age, and reason for visit. Twenty five hundred and fifty five patients
were seen over the 9-day study period. Fourteen hundred and forty patients had a random
blood glucose level resulted by the lab. 106 patients had a blood glucose level >150
mg/dL without a history of diabetes. Forty-two and a half percent (n= 45) of the 106
patients were discharged, 50% (n=53) were admitted, and the rest (n~8) were transferred
to another hospital or a psychiatric unit for admission. O f those discharged (n=45), only
one patient (2.2%) was informed about the elevated blood glucose level and referred for
follow-up.
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CHAPTER I
STATEMENT OF THE PROBLEM
Prediabetes is prevalent, continues to increase, and costs the United States over
$25 billion annually (Zhang et al., 2009). A patient may have prediabetes and its adverse
micro- and macro-vascular complications for up to seven years before diabetes is
diagnosed (Aroda & Ratner, 2008; Harris, Klein, Welton, & Knulman, 1992). Early
identification and treatment o f patients who may have undiagnosed prediabetes is
essential in preventing or delaying progression to type 2 diabetes (Bergman, 2010;
Hsueh, Orloski, & Wyne, 2010). In 2011, 79 million Americans had prediabetes, and
seven million were undiagnosed (American Diabetes Association [ADA], 201 lb).
Incidence is expected to increase to 472 million people worldwide by 2025 (Shehab
Eldin, Emara, & Soker, 2008). Mitigating this global public health issue requires
identifying those with undiagnosed prediabetes and initiating measures to stop or delay
progression to type 2 diabetes (Bergman, 2011).
Background and Significance
The National Diabetes Data Group (1979) originated the concept of impaired
glucose tolerance (IGT), a condition exemplified by an elevated blood glucose level that
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was not diabetes but increased a person’s risk for diabetes (Abdul-Ghani & DeFronzo,
2009). In 1997, the Expert Committee on the Diagnosis and Classification of Diabetes
Mellitus further elaborated this phenomenon to include another category called impaired
fasting glucose (IFG). They argued an elevated IGT or IFG, or both, indicated increased
risk for type 2 diabetes mellitus and constituted prediabetes (Abdul-Ghani & DeFronzo,
2009; Buysschaert & Bergman, 2011).
Prediabetes mellitus, a term coined over a decade ago by the U.S. Department of
Health and Human Services and the ADA (Shehab Eldin, Emara, & Shoker, 2008), is
defined as a state in which cells no longer respond appropriately to insulin, a hormone
that regulates blood sugar (Vagnini, 2010). Prediabetes is considered a diagnosis, but it is
also considered a risk state that warrants consideration of lifestyle changes and
medication to reduce the risk of progression to type 2 diabetes (Shaw, 2011).
Normal blood glucose levels increase after eating a meal but should not exceed
135-140 mg/dL (Charfen, Ipp, Kaji, Saleh, Qazi, & Lewis, 2009). A review of the
literature finds a lack of consensus in what constitutes a blood level indicative of elevated
blood glucose. For example, a random non-fasting blood sugar level in a person without
diabetes should be in the low to mid-100’s mg/dL (Virginia Mason Team Medicine,
2013).
Other sources argue a random blood sugar in a healthy person without diabetes,
should be less than 125 mg/dL (WebMD, 2011). In contrast, Ginde, Savaser, and
Camargo (2009) defined anything less than 140 mg/dL to be a normal glucose level. The
ADA defines hyperglycemia in the hospital setting, which includes the emergency
department (ED), as a blood glucose >140 mg/dL (ADA, 2012). Although a recent meal,
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stress, medications, infections, and pain may result in an elevated blood glucose level
(Davidson & Moreland, 2009), the elevated level may also be an indicator of prediabetes,
which warrants further testing (Ginde, Delaney, Pallin, & Camargo, 2010).
Prediabetes risk or diagnosis is determined by performing specific tests such as a
fasting blood glucose test. The result is impaired fasting glucose (IFG). Prediabetes is
defined as elevated blood glucose levels with IFG between 100 and 125 mg/dL (AbdulGhani & DeFronzo, 2009). However, others argue an IFG level with anything greater
than 90 mg/dL puts a patient at risk and should be considered the level for prediabetes
(Nichols, Hiller, & Brown, 2008; Shaw, Zimmet, & Hodge, 2000). IGT levels between
140 and 200 mg/dL or elevated IFG and IGT are considered to be indicative of
prediabetes (Biuso, Butterworth, & Linden, 2007; Fonseca, 2007; Zhang et al., 2009). In
prediabetes, the serum blood glucose levels are elevated but are not high enough to be
diagnosed as type 2 diabetes (Canadian Diabetes Association, 2012; Fonseca, 2007),
nonetheless if left untreated, people with elevated blood glucose levels are predisposed to
develop type 2 diabetes (Biuso, Butterworth, & Linden, 2007; Fillman, 2010; Fonseca,
2007; Gossaine & Aldosouqi, 2010; Shehab Eldin, F.mara, & Soker, 2008).
In 2010, the ADA recommended another important lab test for identifying
prediabetes, the glycolated hemoglobin A le (Also known as: A le, HgAlc or HbAlc).
This blood test provides a snapshot of what the blood glucose concentration has been
over a period of time (Dugger & Clark, 2011), specifically the average plasma glucose
from the prior 90 days. An A1C of 5.7% to 6.4% is considered to be indicative of
prediabetes (ADA, 2010; Buysschaert & Bergman, 2011; Dugger & Clark, 2011;
Silverman et al., 2011).
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Access to Care
For many, the Emergency Department (ED) is the only source of medical care or
interaction with a health care provider. This makes the ED an ideal place to identify those
with elevated random blood glucose levels and refer them for more specific testing for
prediabetes and diabetes (Charfen et al., 2009; Ginde et al., 2010; Silverman et al., 2006).
Because ED patients may have had oral intake before arriving in the ED, the serum blood
glucose level is considered random (unknown last oral intake; Fonseca, 2007).
In 2004, the ADA recommended early detection of prediabetes (Charfen et al.,
2009). This suggests screening of the general population for prediabetes would be
beneficial. Norris, Kansagara, Bougatsos, and Fu (2008) published a review of the
evidence debating the benefits or harm of screening and found a lack of evidence to
support universal screening. In 2011, the ADA revisited the issue and recommended
standardized protocols for screening. Unfortunately, screening for prediabetes is not
routinely done.
Health care professionals regularly care for patients experiencing the phenomenon
of elevated blood glucose in a variety of settings, including hospitals, emergency
departments, doctor’s offices, and clinics. In 2008, the American Association of Clinical
Endocrinologists urged physicians to identify prediabetes and begin treatment, such as
lifestyle changes, including diet, exercise, and possible medication use. Lifestyle
modification has been shown to prevent or delay the risk of progression from prediabetes
to type 2 diabetes by up to 58% (Diabetes Prevention Program Research Group, 2002;
Tuomilehto et al., 2001). With the incidence o f diabetes increasing each year, a chance to

5

identify patients with possible prediabetes who could make lifestyle changes to prevent
progression to type 2 diabetes is an important health promotion opportunity that should
not be missed.
Several landmark studies have shown the efficacy of lifestyle modifications such
as diet, exercise, and even the addition of medication to prevent advancement from
prediabetes to diabetes (Diabetes Prevention Program Research Group, 2002; Lindstrom
et al., 2003; Pan et al., 1997). The health care system is burdened with patients who
present with multiple comorbidities. Prevention of health care complications is necessary,
but impossible unless patients are educated about their risk and informed if they have
abnormal laboratory results. The Affordable Care Act addresses the need for prevention,
including the need to identify and prevent diseases (Koh & Sebelius, 2010).
Early identification will give patients the opportunity to make lifestyle choices to
prevent or delay progression to type 2 diabetes, thus preventing negative impact on the
individual, society, health care system, and health care costs (Biuso et al., 2007; Cali &
Caprio, 2008; Fonseca, 2007; Hoerger et al., 2007; James et al., 2011). Lifestyle
modification has been shown to prevent or delay the risk of those with prediabetes from
progressing to type 2 diabetes by up to 58% (Diabetes Prevention Program Research
Group, 2002; Tuomilehto et al., 2001).
Notably, the ED may be an opportune location for identifying patients with
prediabetes (Ginde, Delaney, Lieberman, Vanderwell, & Camargo, 2007), which is key
in gaining control of this growing epidemic (Colagiuri, 2011). Although previous studies
have reported conflicting findings regarding the percentage of patients presenting to the
Emergency Department with blood glucose levels suggesting prediabetes, the ED is
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recognized as an ideal place to identify, inform, and refer patients for follow-up (Ginde et
al., 2007).
The purpose of this study was to examine (1) the rates of elevated blood glucose
levels >150 mg/dL in adults without a history of diabetes, receiving care for a non
diabetes related emergency room visit and (2) Emergency Department provider patterns
of informing and referring discharged patients without a history of Diabetes Mellitus
(DM) for follow-up of elevated random blood glucose levels.
Conceptual Framework
To study the importance of recognizing and responding to elevated blood glucose
levels in the emergency department, Pender’s Health Promotion Model is the conceptual
framework guiding this study (Figure 1). Nola J. Pender, a health promotion advocate,
created the health promotion model in 1982 and revised it in 1996 (Nursing Planet,
2012). According to Pender, health promotion and disease prevention should be the
primary focus in health care. Health promotion, an approach to wellness, is defined as
behavior motivated by the desire to increase well-being and actualize human health
potential. This model was created to show the relationships between individual
characteristics and experiences, behavior specific conditions and affects, and behavioral
outcomes. Pender advocated addressing health issues and behaviors in an effort to
promote health and prevent disease (Nursing Planet, 2012).
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Figure 1. The revised health promotion model (Pender, 1996).

Identification o f an elevated blood glucose level (>150 mg/dL), during a non-diabetes
related visit to the ED fits into Pender’s Conceptual Model. The middle column labeled
“Behavior-Specific Conditions and Affect” shows an opportunity for an interpersonal
influence. An example occurs when a provider informs a patient about an elevated blood
glucose value and refers him or her for follow-up testing. When the patient follows up
with another provider, he or she is making a “commitment to a plan of action” as listed
on the model. If follow-up testing shows the patient has prediabetes, he or she will be
able to make lifestyle changes and start a treatment regimen to change the course of the
disease process.
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Research Questions
The research questions to be answered in this study are
1. What are the characteristics of a group of adults (random blood glucose, Body
Mass Index [BMI], blood pressure [BP]), and select demographic
characteristics (age, gender, race/ethnicity) receiving care for a non-diabetes
related visit to the ED?
2. What are the relationships between and among the dependent variable of
blood glucose level and independent variables (BMI, elevated BP [>130/80],
history o f hypertension, previous blood glucose >150 mg/dL and selected
demographic characteristics) in a group of adults receiving care for a non
diabetes related visit to the ED?
3. What are the rates of elevated blood glucose >150 mg/dL in adults without a
history o f diabetes receiving care for a non-diabetes related emergency room
visit?
4. What are emergency department provider patterns of informing and referring
discharged emergency department patients without a history of diabetes for
follow-up o f elevated random blood glucose in a group of adults receiving
care for a non-diabetes related visit to the ED?
Specific Aims
1. To characterize a group of adults (random blood glucose, Body Mass Index
[BMI], blood pressure [BP]), and select demographic characteristics (age,
gender, race/ethnicity) receiving care for a non-diabetes related visit to the
ED.

2. To describe the relationships between and among the dependent variable of
blood glucose level and independent variables (BMI, elevated BP [>130/80],
history of hypertension, previous blood glucose >150 mg/dL, and selected
demographic characteristics) in a group of adults receiving care for a non
diabetes related visit to the ED.
3. To examine the rates of elevated blood glucose >150 mg/dL in adults without
a history of diabetes receiving care for a non-diabetes related emergency room
visit.
4. To examine emergency department provider patterns of informing and
referring discharged emergency department patients without a history of
diabetes for follow-up of elevated random blood glucose in a group of adults
receiving care for a non-diabetes related visit to the ED.
Nursing Implications
Nurse scientists are focusing on research to improve patient health and outcomes.
Pender’s Health Promotion Model theorizes health care providers, which for the purpose
of this study include nurses, physicians, and physician assistants, have interpersonal
influence through their communication with patients. Communication about lab tests and
findings can help influence and encourage patients to take an active role in improving
health and well being.
It is highly probable the ED visit may be the only opportunity for some patients to
interface with a health care provider. This makes the ED an ideal place to identify
elevated blood glucose levels, refer patients for follow-up of the elevated blood glucose
level, and stress the importance of follow-up. ED nurses and providers play a key role in
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affecting the opportunity for patients to make important choices about health and well
being. With proper referral and follow-up to diagnose prediabetes, the patient will be able
to make important decisions and changes in lifestyle to prevent further progression of this
risk state.
The results of this study will inform nurses and providers about this patient
population who may have undiagnosed prediabetes or type 2 diabetes. It will increase
their awareness of the current missed opportunities for educating patients to allow them
to make choices to delay or prevent progression to type 2 diabetes. The results will
increase ED provider awareness of the rate of patients with a blood glucose level greater
than or equal to 150 mg/dL and encourage them to refer patients for follow-up. Followup for discharged patients could entail further assessment of lab values such as a fasting
blood glucose, a glucose tolerance test, or an A 1C.
The health care system is already burdened with the number of patients with
multiple comorbidities. Prevention of health care complications is critical but impossible
unless patients are informed of their risk. The Affordable Care Act addressed the need for
prevention, which includes the need to identify and prevent diseases (Koh & Sebelius,
2010). While screening patients for diabetes is not recommended (Norris et al., 2008), it
is recommended that patients with an elevated blood glucose level be informed and
referred (Bergman, 2010; Hsueh et al., 2010).
With the growing numbers of prediabetics each year, EDs need to adopt protocols
to inform and refer patients with elevated blood glucose levels. Nurses must partner with
ED providers (physicians and physician assistants) to educate patients about the risks and
complications of prediabetes and the opportunity to make changes to prevent or delay
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progression to type 2 diabetes. ED nurses and providers play an integral role in affecting
the ability for patients to make important choices about their health and well-being.

/

CHAPTER II
REVIEW OF THE LITERATURE
The purpose of this chapter is to provide a summary of the literature about
elevated blood glucose levels and prediabetes. It will include methods for testing (fasting
glucose test, glucose tolerance test, and A le) for this risk state that predisposes patients
eventually to progress to type 2 diabetes. Risk factors for elevated blood glucose levels
such as body mass index (BMI), elevated blood pressure, age, gender, and race/ethnicity
will also be presented. Studies will be presented that support the importance of
identifying patients with elevated blood glucose levels and informing and referring them
for follow up testing in an effort to identify the risk state of prediabetes. Although there is
support for testing, it is unclear what blood glucose level should be used as the cutoff
point for referring patients. Gaps in the literature are identified to establish the need for
this study.
Conceptual Framework
Pender’s Health Promotion Model (Figure 1) was the conceptual framework
guiding this study. This framework was chosen because the premise is patients will
respond to the interpersonal influences of an ED provider informing and educating them
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about an elevated random blood glucose level. When the provider explains the risk:,
involved, refers the patient for follow up, and urges the patient to follow up for further
testing, this will lead to the patient to making a commitment to action. The patient will
follow up for further testing and then if they do, in fact, fit the criteria for the prediabetes
risk state, the patient can make important decisions about lifestyle modifications to
improve his or her health and well-being.
In a study conducted by Ginde et al. (2007), patients were supportive of the idea
of screening for diabetes. Two-thirds (n=604) of their patients were willing to have their
blood drawn and tested to screen for diabetes. Ninety five percent said they would follow
up if their value was abnormal and wanted to be informed. Nearly all stated they wanted
to be referred for outpatient follow-up. This work provides support for the use of this
framework for the study conducted here.
Principal Literature Review
A comprehensive literature search was conducted using Cumulative Index to
Nursing Allied Health Literature (CINAHL) Plus with full text, Google Scholar, and
evidence-based medical reviews: Cochrane DSR, ACP Journal Club, DARE, CCTR,
CMR, HTA and NHSEED, Ovid SP, and PubMed. Key search terms were prediabetes,
elevated glucose, diabetes, A 1C, BM1, and prediabetes screening. Additional articles
were found using the reference list from cited articles.
Elevated Blood Glucose Levels
Normal blood glucose levels increase after eating a meal but should not exceed
135-140 mg/dL (Charfen et al., 2009). A review of the literature finds a lack of consensus
in what constitutes a blood glucose level indicative of “elevated blood glucose.” For
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example, a random blood glucose level in a person without diabetes should be in the low
to mid-lOO’s mg/dL (Virginia Mason Team Medicine, 2013). For Ginde et al. (2009), any
level less than 140 mg/dL is considered a normal glucose level. Others argue a random
blood sugar, even in a healthy person without diabetes, should be less than 125 mg/dL
(WebMD, 2011). The American Diabetes Association defines hyperglycemia in the
hospital setting, which includes the Emergency Department, as any blood glucose >140
mg/dL (ADA, 2012). Although a recent meal, stress, medications, infections, and pain
may result in an elevated blood glucose level (Davidson & Moreland, 2009), the elevated
level may also be an indicator of prediabetes, which warrants further testing (Ginde et al.,
2010 ).

An elevated blood glucose level is a warning there may be a problem, but followup tests are critical. Patients diagnosed with both impaired fasting glucose (IFG) and
impaired glucose tolerance (IGT) are twice as likely to develop type 2 diabetes as those
with isolated IFG or isolated IGT (Nathan et al., 2007). The term impairedfasting
glucose, coined in 1997, refers to fasting plasma glucose (FPG) levels greater than 110125 mg/dL (Expert Committee on the Diagnosis & Classification of Diabetes Mellitus,
1997). In 2003, the same committee lowered the FPG level to 100 mg/dL (Expert
Committee on the Diagnosis & Classification of Diabetes Mellitus, 2003). The term
impaired glucose tolerance was defined by the National Diabetes Data Group as an IFG
level >100 to < 126 mg/dl and an IGT >140 to <200 mg/dL (1979).
In 2010, the ADA recommended another important lab test for identifying
prediabetes called the glycolated hemoglobin A le (also known as: A le, HgAlc or
HbAlc). This blood test shows the average plasma glucose from the prior 90 days. It is a
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snapshot o f what the blood glucose concentration has been over a period of time (Dugger
& Clark, 2011). An A le of 5.7% to 6.4% is considered to be indicative of prediabetes
(ADA, 2010; Buysschaert & Bergman, 2011; Dugger & Clark, 2011; Silverman et al.,
2011).
Early identification is the first step at preventing those with prediabetes from
progressing to type 2 diabetes (Gossaine & Aldosouqi, 2010). Previous studies have
indicated the ED is the ideal place to identify, inform, and refer patients for follow-up
care and patients are receptive to this information and want to be notified (Ginde et al.,
2007).
Ginde et al. (2009) examined if ED patients with blood glucose levels >140
mg/dL were informed of their elevation and if recommendation for follow-up was
provided. Twenty-one percent of the ED patients had glucose levels >140 mg/dL, yet
when written discharge instructions were reviewed, less than 10% were informed about
their elevated blood glucose level or were referred for follow up and further testing. A
prior study by Ginde et al. (2007) showed 95% of ED patients want to be informed if they
had an elevated blood glucose level.
Ginde et al. (2010) recognized the ED is an ideal place to identify patients with
undiagnosed diabetes. They conducted a study of 152 ED physicians to examine
prediabetes screening of asymptomatic patients in the ED, what glucose threshold ED
physicians thought warranted treatment and referral, and the barriers to referral. Findings
indicated 53% supported screening and 92% endorsed they should inform non-diabetic
patients about an elevated blood glucose level. Respondents indicated a blood glucose
value greater than or equal to 200 mg/dL warranted referral, but 71% believed they
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should refer for a lower blood glucose value. Approximately 25% thought they should
refer as low as 160 mg/dL and 5% thought they should refer for a blood glucose level of
125 mg/dL in a non-diabetic patient.
The physicians cited several barriers to referral. Barriers for not informing and
referring patients about elevated glucose levels included insufficient time and resources,
outside their scope of practice, and lack of clearly defined blood glucose levels for
referral and follow-up. The providers thought the Emergency Department was a good
place to identify those at risk of prediabetes or those with uncontrolled diabetes, they did
not feel screening those without symptoms was necessary (Ginde et al., 2010).
Combined, these studies demonstrate a knowledge gap among practitioners.
Specifically, those patients who had elevated blood glucose levels and who should have
been referred often were not. More basic in this process, blood glucose levels warranting
referral and follow up are not clearly defined.
Risk factors for prediabetes have been identified by the Canadian Diabetes
Association (2012) and the American Diabetes Association (2011): obese patients are at
increased risk (Fonseca, 2007; Gossaine & Aldosouqi, 2010; Kenealy, Elley, & Arroll,
2007) and assessment is recommended for asymptomatic patients with a BMI greater
than or equal to 25 kg/m2, high blood pressure, and belonging to a high risk population
(e.g., Aboriginal, Hispanic, Asian, South Asian, or African descent) (Canadian Diabetes
Association, 2012).
Risk Factors
Demographics and other factors such as elevated BMI and high blood pressure
have been found to increase the risk of having an elevated blood glucose level. An
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elevated BMI (Bergman, 2010), blood pressure, older age, and belonging to a high-risk
racial or ethnic group further places the patient at risk (Charfen et al., 2009; Shaw, 2011;
Shehab Eldin et al., 2008) and should be considered by the ED team when evaluating a
patient. A study by James et al. (2011) found variables such as age, gender, race, and
different prediabetes measures (IFG, OGT, and A le) yield varying results. Their findings
did not point to any specific test that was the defining test for the risk state of prediabetes.
Body mass index (BMI). Obesity, which is defined as a BMI greater than or
equal to 30 kg/m2, is a known risk factor for diabetes. In fact patients with BMI >25
kg/m2, which is considered overweight, are also at risk. Recently a study by Chiu,
Austin, Manuel, Shah, and Tu (2011) found BMI cutoffs for assessing diabetes risk vary
depending on ethnicity. They looked at BMI 30 kg/m2 as the highest risk for Caucasian
participants but discovered lower BMIs put other ethnic groups at risk. The South Asian
group developed diabetes with a BMI of 24 kg/m2, the Chinese group at 25 kg/m2, and
the Black group at 26 kg/m2. These findings support the idea people are at an increased
risk of developing diabetes with a BMI as low as 24 kg/m2.
Hoerger et al. (2007) screened 45-74 year old overweight or obese patients with a
BMI greater than or equal to 25 kg/m2 for prediabetes. They used a random capillary
blood glucose test. One hundred mg/dL was used as the indicator for having a positive
test. Those screening positive received either a fasting plasma glucose test (FPG) or an
oral glucose tolerance test (OGT). For those with a positive FPG or OGT, a second FPG
or OGT was conducted for confirmation purposes. Next, patients with prediabetes
received Diabetes Prevention Program (DPP) interventions (3 lifestyle modifications
such as weight loss or 150 minutes of weekly physical activity or medication -
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metformin). An earlier study (Herman et al., 2005) found these lifestyle modifications
were cost-effective and resulted in a reduction in risk for progressing to type 2 diabetes.
Hoerger et al.’s (2007) findings supported those of Herman et al. (2005), arguing
identification of predictors allows individuals to make lifestyle changes necessary to
prevent the progression to type 2 diabetes.
Blood pressure. It is well documented a history of hypertension increases the risk
of a patient having elevated blood glucose levels; thus, hypertension is a risk factor that
should prompt screening for diabetes (Gossaine & Aldosouqi, 2010). The United States
Preventative Task Force also recommends screening those who are asymptomatic with
hypertension, a blood pressure greater than 135/80 mm/Hg (Gossaine & Aldosouqi,
2010). Ginde et al. (2009) studied 185 patients with blood glucose levels >140 mg/dL
and of those, 54% had a history of hypertension. Elliott (2008) noted those with
prediabetes should follow the same recommendation as those with diabetes, which is to
maintain a blood pressure less than 130/80 mmHg.
Age. Ginde et al. (2009) found 64 to be the median age of those with blood
glucose levels >140 mg/dL, which could be a sign of prediabetes. A study conducted by
James et al. (2011) supported similar findings that age increases the prevalence of having
elevated A le levels, IGTs, and IFGs. Chiu et al. (2011) examined the incidence of
diabetes in a multiethnic cohort study of 59,825 participants and found the median age
for developing diabetes in South Asians was 49 years, Chinese 55 years, Blacks 57 years,
and Whites 58 years.
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The ADA recommends adults aged 45 or older be tested for elevated blood
glucose levels and recommends repeat blood tests every three years. Those with other
risk factors should be tested earlier (ADA, 201 la). The Canadian Diabetes Association
recommends everyone aged 40 or above is tested by a fasting plasma glucose test with a
retest every three years (2010). This study looked at a cohort of adult patients to see what
age correlates with a blood sugar level 2:150 mg/dL.
Gender. There is a lack of clarity surrounding gender and increased risk of
developing prediabetes and diabetes. Ginde et al. (2009) found no difference in risk
related to gender. James et al. (2011) found no significant gender differences in elevated
A le and IGT levels; however, men were more likely than women to have elevated IFG.
In contrast, Chiu et al. (2011) found men had diabetes more often than women. Their
study focused on ethnic differences and found the exception was with Black patients;
women were 33% more likely to have diabetes as compared to men.
Race/ethnicity. Race and ethnicity have been cited as increased risk factors for
prediabetes and diabetes but studies vary in their findings about which groups are at the
greatest risk. Ginde et al. (2009) found 67% of their study participants with elevated
blood glucose levels greater than 140 mg/dL were White, 17% Black, 4% Hispanic, and
12% listed as “Other.” Chiu et al. (2011) conducted a multiethnic cohort study of 59,824
participants (White, South Asian, Chinese, and Black). Their findings indicated the South
Asian group had the highest incidence of developing diabetes, followed by the Black,
White, and Chinese groups.
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The major limitation of this study was the number of participants in the nonWhite groups was significantly smaller than those in the White group. A study by James
et al. (2011) found when A le was used to test for prediabetes, non-Hispanic Blacks were
almost twice as likely as non-Hispanic Whites and Mexican Americans to test positive.
When IFG and IGT were used to measure risk, non-Hispanic Whites and Mexican
Americans were twice as likely as Non-Hispanic Blacks to have elevated levels indicative
of prediabetes. Prediabetes prevalence was similar between non-Hispanic Whites and
Mexican Americans. The various findings among groups leaves a knowledge gap about
which group is at the greatest risk. This study looked at race/ethnicity in the population at
two EDs to see which group has the highest rate of elevated blood glucose levels £150
mg/dL.
Informing and Referring
This study is founded on the assumption that an ED patient should be informed
about an elevated random blood glucose level so he or she can follow up for further
testing to determine prediabetes status. Charfen et al. (2009) conducted a study to identify
patients with elevated blood glucose in the ED and refer them for follow-up testing. Their
findings indicated patients with a random blood glucose level >155 mg/dL and two risk
factors end being diagnosed with diabetes or prediabetes.
Ginde, Cagliero, Nathan, and Camargo (2008) conducted a study in the
Emergency Department to look for prevalence of undiagnosed diabetes and examined the
correlation between random point o f care (POC) glucose levels and A le. A total of 265
participants had A le levels tested by point of care (POC) device and lab processing. If

the A le level was elevated, the participants were referred for an oral glucose tolerance
test. For the correlation between serum glucose level in the Emergency Department and
the A le, they controlled for age, gender, and race/ethnicity.
Findings indicated 29% of ED patients without prior diagnosis of diabetes had
abnormal A le levels and when tested further, prediabetes or diabetes was confirmed in
72% of those that had follow-up oral glucose testing. This finding was limited because
only 38% of those referred went for the recommended follow up testing. Although this
number is high, it does not give an accurate percentage of the population who had
prediabctes (14%). This study was, however, helpful in supporting the idea of the ED
being an ideal setting to access those who may have prediabetes or diabetes. Their
findings indicated blood glucose values greater than 120 to 140 mg/dl. have sufficient
specificity to warrant further testing. This finding supports this study and the idea that
identifying those with an elevated blood glucose level and referring them for follow-up
testing is vital. Failure to do this is a missed opportunity to identify potentially at-risk
patients.
Once a patient is referred for follow-up and is found to have prediabetes, he or she
can choose to make lifestyle choices to affect their health outcomes. This is consistent
with Pender’s Health Promotion Model as a framework for this study. Several landmark
studies have been conducted to show the efficacy of lifestyle modifications such as diet,
exercise, and even the addition of medication to prevent advancement from prediabetes to
diabetes. Informing patients o f their risk is key for them being able to make a decision to
affect their future health. The Da Qing IGT and Diabetes Study showed those who did
not make any lifestyle changes had an increased risk of developing type 2 diabetes, where
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those who had a change in diet, exercise, or both had a significant decrease in incidence
o f progressing to type 2 diabetes (Pan et al., 1997). This was supported in 2002, when the
Diabetes Prevention Program found lifestyle modifications such as diet and exercise
alone, and also with the addition of a medication called metformin, helped prevent
progression from prediabetes to type 2 diabetes (Diabetes Prevention Program Research
Group, 2002).
This was further supported by the Finnish Diabetes Prevention Study findings that
patients can alter the course of their health with lifestyle modification (Lindstrom et al.,
2003). The goal o f this study is to describe the numbers of patients being seen in two EDs
with elevated blood glucose levels who are not being informed. The findings will
demonstrate the missed opportunity for referral, which ultimately will result in the patient
not being able to make a life-altering health care decision. The intent is to heighten
awareness among ED nurses and health care providers about the rate of patients
potentially at risk who need to be identified and informed of their elevated blood glucose
levels.
Charfen et al. (2009) conducted a two-year cohort study with 528 non-diabetic
patients. Inclusion criteria were ED blood glucose levels >140 mg/dL or >126 mg/dL if
more than two hours since last food intake or at least two diabetes risk factors, being a
member o f a high risk racial or ethnic group (African American, Hispanic, Native
American, Asian American, or Pacific Islander), age 45 years or older, BMI >25 kg/m2,
or hypertension treated with medication. These risk factors are highlighted, as they are
relevant to this study. Prior researchers determined those with fasting blood glucose
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levels between 100 and 149 mg/dL and A1C between 5% and 7.9% would be classified
as prediabetic.
A blood glucose level of >150 mg/dL was selected for this study because a
normal blood glucose level should be less than 125-140 mg/dL, even after eating a meal
(ADA, 2012; Charfen et al., 2009; WebMD, 2011). Prior studies have used the values of
>140 mg/dL as their cutoffs for those that should be referred for further testing for
prediabetes (Ginde et al., 2009). The decision was also based on the prior study by Ginde
et al. (2010) that found providers would refer at 200 mg/dL but thought they should refer
for values greater than 160 mg/dL. Some even thought they should refer for a blood
glucose value greater than 125 mg/dL.
The value o f >150 mg/dL has not been examined in any prior studies so will be
used for this one as the cutoff for examining and describing those without history of DM.
This study will also look to see how elevated blood glucose levels correlate with other
factors such as age, gender, ethnicity/race, BMI, and blood pressure.
Summary of Literature Review
A review of the extant literature finds (1) variation in glucose threshold levels for
prediabetes; (2) various risk factors such as BMI, elevated BP, age, gender, and
race/ethnicity increase the likelihood of having prediabetes; (3) provider attitudes and
practices involved in informing patients about their elevated blood glucose levels and if
referred for follow up (notably, education and referral for elevated blood glucose levels is
not commonly implemented in the ED setting); and (4) patient attitudes and preferences
to be informed and intentions to follow-up on an elevated blood glucose level.

CHAPTER III
METHODS

The purpose o f this study was to examine (1) the rates of elevated blood glucose
levels >150 mg/dL in adults without a history of diabetes receiving care for a non
diabetes related emergency room visit and (2) emergency department provider patterns of
informing and referring discharged ED patients without a history of DM for follow-up of
elevated random blood glucose levels. In this chapter a description of the design, sample,
data collection, and analytic techniques will be presented. The protection o f human
subjects and study limitations will also be addressed.
Specific Aims
1. To characterize a group of adults (random blood glucose, Body Mass Index
[BMI], blood pressure [BP]) and select demographic characteristics (age, gender,
race/ethnicity) receiving care for a non-diabetes related visit to the ED.
2. To describe the relationships between and among the dependent variable of blood
glucose level and independent variables (BMI, elevated BP [>130/80], history of
hypertension, previous blood glucose >150 mg/dL) and selected demographic
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characteristics in a group of adults receiving care for a non-diabetes related visit to
the ED.
3. To examine the rates of elevated blood glucose >150 mg/dL in adults without a
history of diabetes receiving care for a non-diabetes related emergency room visit.
4. To examine Emergency Department provider patterns of informing and referring
discharged emergency department patients without a history of diabetes for
follow-up of elevated random blood glucose in a group of adults receiving care
for a non-diabetes related visit to the ED.
Design
A descriptive, correlational, cross-sectional design, with purposive sampling was
selected for this study. Descriptive indicates the examination of variables to show what
exists; the purpose of descriptive research is to accurately describe a phenomena (Key,
1997). Correlation designs are used to describe relationships among variables without
seeking a cause and effect. This type of non-experimental design was appropriate for the
current study because the intent was to assess whether or not a relationship exists
between variables without concern for the original reason or cause of variables being
studied. With this type o f design, no manipulation or treatment of variables is necessary
(Munro, 2005). According to Polit and Tatano Beck (2006), “Cross-sectional designs are
especially appropriate for describing the status of phenomena or relationships among
phenomena at a fixed point” (p. 192).
Sample and Setting
Participants were selected from all adult patients (18 years and older) seeking
medical services for non-diabetes related reasons from two EDs located in North San
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Diego County (N=2,555), March 1,2010 through March 22, 2010. The two hospitals are
part o f a community-based health care system comprised of two acute care hospitals, a
long-term care facility, a skilled nursing facility, and a surgery center. One ED has
approximately 30,000 patient visits per year and the other approximately 70,000 patient
visits per year. A purposive sample was selected based upon the inclusion criteria: blood
glucose obtained and result logged in the electronic medical record (EMR).
Power Analysis
To avoid type 2 errors, strengthen statistical conclusions, and have a large enough
effect size, a power analysis was completed to estimate sample size necessary for this
proposed study (Polit & Tatano Beck, 2012). Using Green’s (1991) formula N=50 + 8m
(m is the number of independent variables), 50 + [8x9] = 50 + 72=122. At minimum, 122
participants were necessary for this study, to test multiple correlations.
Variables and Operational Definitions
Table 1 lists the variables and type of variables used for this study. Operational
definitions are outlined as well.
Table 1
Variables and Operational Definitions
Variable/Type of Variable

Operational Definition

Elevated blood glucose level (continuous)

Blood glucose level £150 mg/dL

Body Mass Index (BMI) (continuous)

BMI is the ratio of weight in kilograms to
the square of height in meters, calculated
according to the Centers for Disease Control
and Prevention adult charts.

Elevated Blood Pressure (nominal/categorical) Blood pressure £130/80 - Yes or No
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Prior blood glucose £150 mg/dL
(nominal/categorical)

Yes, No, or N/A

Age (continuous)

Age range is 18-99 years old

Gender (nominal/categorical)

Male or female

Race/Ethnicity (nominal/categorical)

Caucasian, Hispanic, Asian or Pacific
Islander, Black, Other, Unknown

History of Hypertension (nominal/categorical) Yes or No
History o f Diabetes (nominal/categorical)

Yes or No

Marital status (nominal/categorical)

Married, Single, Divorced, Widowed,
Separated, Unknown

Reason for visit to the ED
(nominal/categorical)

Abdominal, Cardiac, Neurologic,
Respiratory, Other

Discharged from the Emergency Department Yes or No
(nominal/categorical)
Informed about elevated blood glucose level
(nominal/categorical)

Yes or No

Referred for follow up of elevated blood
glucose level (nominal/categorical)

Yes or No

Data Collection
Retrospective data were obtained from electronic medical records (EMRs) of ED
patients 18 years or older seeking medical services unrelated to diabetes in two EDs in
Southern California. An investigator-developed data abstraction form was used. Data
were abstracted from the EMRs of patients seen on Monday, Wednesday, or Friday from
March 1,2010 through March 22,2010, who had a blood glucose drawn and the result
logged in the EMR (N=193).
Data Analysis
Descriptive and inferential statistics were used in this study as “an important
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aspect of statistical inference involves reporting the likely accuracy or degree of
confidence, o f the sample statistic that predicts the value of the population parameter”
(Munro, 2005. p. 5). Descriptive statistics (means, standard deviations, percentages) were
employed to illustrate the characteristics of the participants. Correlations were used to
examine the relationships between blood glucose level, BMI, elevated BP (>130/80),
history o f hypertension, previous blood glucose >150 mg/dL, reason for visit, and
selected demographic characteristics (age, gender, race/ethnicity, marital status). To
describe the relationships among the variables, first a correlation matrix was constructed
to identify the potential for multicollinearity, which can occur when there are moderate to
high correlations among predictor variables. Predictor variables scrutinized for moderate
to high correlations can possibility be deleted and one variable will be reported, or
variables may be combined to represent one measure of a construct to delete repetition
(Mertler & Vannatta, 2010).
In the data reported here, no multicollinearity was evidenced; therefore,
relationships between the independent and dependent variables will be reported using
Pearson’s r, Phi, and Cramer’s V. A correlation is a number that describes the degree of
relationship between two variables. In probability theory and statistics correlation, it is
also known as the correlation coefficient, a numeric measure of the strength o f linear
relationship between two random variables (Munro, 2005).
Pearson’s correlation coefficient r was used to calculate the relationship between
age, BMI, and blood glucose level. Phi coefficient was used to calculate the correlation
between blood glucose level and gender, history of hypertension, and blood pressure
>130/80. Cramer’s V coefficient was used to test the correlation between blood glucose
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level and a previous blood glucose level >150 mg/dL, race/ethnicity, marital status, and
reason for visit. All analyses were conducted using SPSS statistical software, version 19.
Limitations
The findings of this study must be viewed in the context of its limitations. The
sample under investigation was a small although adequately powered purposive sample
o f a racially and ethnically diverse (although fairly homogenous with respect to
regionality) group of patients receiving care in two EDs. Data were obtained through
retrospective review of patient records. Using medical records as a data source introduces
potential error resulting from the quality of data entry. If the patient was informed about
the elevated blood glucose level and referred for follow-up but it was not documented in
the discharge instructions, it was counted as a missed opportunity. Some patients who
met the criteria for this study may have had diabetes, but it may not have been
documented in their medical record. The blood sugar was considered random because
there is no way of knowing when the patient last ate. Blood glucose could have been
elevated because of the stress response, infection, or other medical reasons.
Protection of Human Subjects
Protection o f human subjects included approval by the Institutional Review
Committee at the health system in which the data were collected. Institutional Review
Board approval was also obtained from the University of San Diego. Data were collected
retrospectively. There was no patient contact; therefore, there was no risk or benefit for
the participants. Precautions were taken to protect patient privacy in accordance with the
Health Insurance Portability and Accountability Act (HIPAA); data were de-identified
prior to transferring the information. All data were secured in a password-protected site
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on the researcher’s computer. All paper records, including the codebook, are maintained
in a locked drawer in the researcher’s office. Data will be kept for five years then will be
destroyed.

CHAPTER IV
RESULTS
The purpose o f this study was to examine (1) the rates of elevated blood glucose
levels >150 mg/dL in adults without a history of diabetes receiving care for a non
diabetes related emergency room visit and (2) ED provider patterns of informing and
referring discharged patients without a history of DM for follow-up of elevated random
blood glucose levels. In this chapter, the results are presented. First a descriptive profile
of the study participants, including their random blood glucose level, BMI, elevated BP
>130/80, history of hypertension, previous blood glucose >150 mg/dL, and select
demographic characteristics (age, gender, race/ethnicity) are presented, followed by the
results related to the specific research questions.
Specific Aim #1
To characterize a group of adults (random blood glucose, Body Mass Index
[BMI], blood pressure [BP]) and select demographic characteristics (age, gender,
race/ethnicity) receiving care for a non-diabetes related visit to the Emergency
Department.
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Sample Profile
A total o f 2,555 patients were treated in the 2 EDs over the 9-day period. Of
those, 1,410 had a laboratory-based blood glucose entered and recorded in the EMR. A
purposive sample (n=193) included 106 patients with an elevated random blood glucose
>150 mg/dL, without history of diabetes, and randomly selected patients who may have a
history o f diabetes (n=87).
Study participants (n=193) were fairly evenly distributed (Table 2) by gender,
male (n=91) and female (n=102). Age ranged from 18 to 99 years with a mean (median
65, sd 20.48) age o f 63.8 years. Approximately half (50.8%) were married and more than
three-quarters (76.2%) were Caucasian. Abdominal complaints were the most frequent
reason for visiting the ED (32.6%). Blood glucose levels ranged from 72 to 455 mg/dL
(mean 159.69, sd 51.26; Table 3). BMI ranged from 18 to 44 kg/m2 (mean 26.09, sd
5.30). Twelve percent had a history of diabetes, 47% a history of hypertension, and 54%
had an elevated blood pressure (>130/80) during their ED visit. Thirty-two percent had a
prior blood glucose level >150 mg/dL. Almost half (47.7%, n - 92; Table 4) of the 193
patients were discharged, 46% (n=89) were admitted, and 6.2% (n= 12) were transferred
for admission to another hospital or a psychiatric unit.
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Table 2

Sample Characteristics
Total Sample

BS > 150
No History DM

(N = 193)

(n = 106)

BS in EMR
With/Without
History DM
(n = 87)

Range

63.8 (20.48)
18-99

66.5 (20.79)
20-99

60.54(19.72)
18-95

Gender
n (%)
Male
Female

91(47)
102(53)

54(51)
52 (49)

37 (42)
50 (58)

147 (76.2)

82 (77.4)

65 (74.7)

28(14.5)

14(13.2)

14 (16.1)

6(3.1)
4(2.1)
5 (2.6)
3(1.6)

5 (4.7)
2(1.9)
1 (0.9)
2(1.9)

1(1.15)
2 (2.3)
4 (4.6)
1(1.15)

30(15.5)

16(15.1)

98 (50.8)
19(9.8)
4(2.1)
40 (20.7)

52 (49.1)

14(16)
46 (53)

13 (12.3)
2(1.9)
21 (19.8)

2(1.0)

2(1.9)

6 (6.9)
2 (2.3)
19(21.8)
0

63 (32.6)
30(15.5)
40 (20.7)
12(6.2)
30(15.5)

28 (26.4)

35 (40.2)

13(12.3)
18(17)
10(9.4)
22 (20.8)

17(19.5)
22 (25.3)
2 (2.3)
8 (9.2)

Age
Mean (sd)

Race/Ethnicity
n (%)
Caucasian
Hispanic
Asian
Black
Other
Unknown
Marital Status
n (%)
Single
Married
Divorced
Separated
Widowed
Unknown
Reason for Visit to ED
n (%)
Abdominal
Chest Pain
Neurologic
Psychiatric
Respiratory
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Other

18(9.3)

15(14.2)

3(3.4)

Table 3
Health-Related Parameters
Total Sample

BS >150
No History of
DM

(N = 193)

(n = 106)

159.69 mg/dL
72-455 mg/dL

181.53 mg/dL
150-288 mg/dL

133.09 mg/dL
72-455 mg/dL

105 (54)
88 (46)

52 (49)
54 (51)

53 (61)
34 (39)

62 (32)
101 (52)
30(16)

42 (40)
34 (32)
30 (28)

21 (24)
66 (76)
0

24(12)
169(88)

0(0)
106(100)

23 (26)
64 (74)

91 (47)

54(51)

36(41)

BS in EMR
With/Without
History of
DM
II

P
00

c

Serum Blood
Glucose level
Mean
Range
Blood
Pressure
>130/80
n(% )
Yes
No
Previous
Blood Glucose
>150 mg/dL
n (%)
Yes
No
N/A
History of
Diabetes
n (%)
Yes
No
History of
Hypertensionn
(% )
Yes
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No
BMI
Mean
Range

102(53)

52 (49)

51 (59)

26.09 kg/m2
18-44 kg/m2

25.83 kg/m2
18-44 kg/m2

26.43 kg/m2
18-37 kg/m2

Table 4
Discharge Disposition

Admitted
n (%)
Discharged
n (%)
Transferred
n (%)

Total
Sample
N =193
89 (46.1)

Sample
n = 106
53(50)

92 (47.7)

45 (42.5)

12 (6.2)

8 (7.5)

Specific Aim #2
To describe the relationships between and among the dependent variable of blood
glucose level and independent variables (BMI, elevated BP [>130/80], history of
hypertension, previous blood glucose >150 mg/dL) and selected demographic
characteristics in a group of adults receiving care for a non-diabetes related visit to the
ED.
Research Question #2
What are the relationships between and among the dependent variable of blood
glucose level and independent variables (BMI, elevated BP [>130/80], history of
hypertension, previous blood glucose >150 mg/dL) and selected demographic
characteristics in a group o f adults receiving care for a non-diabetes related visit to the
ED?
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Inferential statistics and correlations were applied to examine the relationships
between the independent variables and the dependent variable.

Table 5
Correlations Between Independent Variables and Blood Glucose Level (n=193)

Independent Variable

Blood Glucose Level
R, Phi(l*or Cramer’s

BMI

.165*

BP >130/80

-.119'

History of
Hypertension
Previous Glucose
>150 mg/dL

.4802**

Age

.157*

Gender

-.0841

Race/Ethnicity

.1602

Reason for Visit
Marital Status

.120'

.3212**
.1322

Notes: r - Pearson’s correlation; *p < .05; **p < .01

Significant relationships were found between blood glucose level and BMI, previous
blood glucose level >150 mg/dL, age, and reason for visit. Increased BMI, history of a
previous blood glucose level >150 mg/dL, increased age, and reason for visit was
significantly related to blood glucose level.
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Specific Aim #3
To examine the rates of elevated blood glucose > 150mg/dL in adults without a
history of diabetes receiving care for a non-diabetes related emergency room visit.
Research Question #3
What are the rates of elevated blood glucose >150 mg/dL in adults without a
history of diabetes receiving care for a non-diabetes related emergency room visit?
Research Question #4
What are the characteristics of adults without a history of diabetes who presented
to the ED with an elevated blood glucose level?
A total of 1,410 patients had a blood glucose level processed by the lab during
this study period. Seven and a half percent (n= 106) met the research criteria of random
blood glucose level >150 mg/dL without a history of diabetes. Age ranged from 20 to 99
years with a mean (median 69, sd 20.8) age of 66.5 years (Table 2). Approximately half
(49%) were married, 51% were male (n=54), and 77% were Caucasian. Abdominal
complaints were the most frequent reason for visiting the ED (26.4%; Table 3).
Nonfasting blood glucose levels ranged from 150 to 288 mg/dL (sd 29.16) with a mean of
181.53. BMI ranged from 18 to 44 kg/m2 (mean 25.83, sd 5.63). Fifty-one percent of
patients had a history o f hypertension and 49% had a blood pressure that was elevated
(>130/80) during their ED visit. Forty percent had a prior blood glucose level >150
mg/dL documented in the medical record but were not diagnosed as having prediabetes
or diabetes. Forty-five (42.5%) of the 106 patients were discharged, 50% (n=53) were
admitted, and the rest (n=8) were transferred to another hospital or a psychiatric unit for
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admission. O f those discharged (n=45), only one patient (2.2%) was informed about
elevated blood glucose level and referred for follow-up.
In contrast, the additional randomly selected patients (n=87) ranged in age from
18 to 95 years, with a mean (median 61, sd 19.7) age of 60.5 years (Table 2).
Approximately half (53%) were married, 42% were male (n=37), and 75% were
Caucasian. Abdominal complaints were the most frequent reason for visiting the ED
(40.2%; Table 3). Nonfasting blood glucose levels ranged from 72 to 455 mg/dL (mean
133.09, sd 59.37). BMI ranged from 18 to 37 kg/m2 (mean 26.43, sd 4.86). Forty-one
percent o f the patients had a history of hypertension and 61% had a blood pressure that
was elevated (>130/80) during their ED visit. Twenty-four percent had a prior blood
glucose level >150 mg/dL documented in the medical record but were not diagnosed as
having prediabetes or diabetes.
Specific Aim #4
To examine ED provider patterns of informing and referring discharged patients
without a history of diabetes for follow-up o f elevated random blood glucose, in a group
of adults receiving care for a non-diabetes related visit to the ED.
Research Question #5
What are ED provider patterns of informing and referring discharged patients
without a history of diabetes for follow-up of elevated random blood glucose in a group
of adults receiving care for a non-diabetes related visit to the Emergency Department?
Results showed out of 106 patients, 45 were discharged and only one (2.2%) was
informed and referred. Forty-four (97.8%) patients were not informed or referred.

CHAPTER V
DISCUSSION OF FINDINGS
The purpose o f this study was to examine (1) the rates o f elevated blood glucose
levels >150 mg/dL in adults without a history of diabetes receiving care for a non
diabetes related emergency room visit and (2) emergency department provider patterns of
informing and referring discharged patients without a history of DM for follow-up of
elevated random blood glucose levels. In this chapter, a discussion of the findings and
implications for nursing practice, education, and research are presented.
Study Summary
Retrospective data abstraction was used to obtain data for the study conducted
here. A total o f 2,555 patients were treated in the 2 EDs over the 9-day data collection
period. O f those, 1,410 had a laboratory-based blood glucose recorded in the EMR. A
purposive sample (n=193) included 106 patients with an elevated random blood glucose
>150 mg/dL without a history of diabetes and randomly selected patients who may have a
history o f DM (n=87).

39

40

Study participants (n=193) were fairly evenly distributed (Table 2) by gender,
male (n=91) and female (n=102). Age ranged from 18 to 99 years with a mean (median
65, sd 20.48) age of 63.8 years. Approximately half (50.8%) were married and more than
three-quarters (76.2%) were Caucasian. Abdominal complaints were the most frequent
reason for visiting the ED (32.6%). Blood glucose levels ranged from 72 to 455 mg/dL
(mean 159.69, sd 51.26; Table 3). BMI ranged from 18 to 44 kg/m2 (mean 26.09, sd
5.30). Twelve percent had a history of diabetes, 47% a history of hypertension, and 54%
had an elevated blood pressure (>130/80) during their ED visit. Thirty-two percent had a
prior blood glucose level >150 mg/dL. Almost half (47.7%, n=92; Table 4) of the 193
patients were discharged, 46% (n=89) were admitted and 6.2% (n=12) were transferred
for admission to another hospital or a psychiatric unit.
Significant relationships were found between blood glucose level and BMI,
previous blood glucose level >150 mg/dL, age, and reason for visit. Increased BMI,
history of a previous blood glucose level >150 mg/dL, increased age, and reason for visit
was significantly related to blood glucose level.
Approximately 7.5% (n=l 06) met the research criteria of random blood glucose
level >150 mg/dL without a history of diabetes. Age ranged from 20 to 99 years with a
mean (median 69, sd 20.8) age of 66.5 years (Table 2). Approximately half (49%) were
married, 51 % were male (n=54), and 77% were Caucasian. Abdominal complaints were
the most frequent reason for visiting the ED (26.4%; Table 3). Nonfasting blood glucose
levels ranged from 150 to 288 mg/dL (sd 29.16) with a mean of 181.53. BMI ranged
from 18 to 44 kg/m2 (mean 25.83, sd 5.63). Fifty-one percent o f the patients had a history
of hypertension, and 49% had a blood pressure that was elevated (>130/80) during their
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ED visit. Forty percent had a prior blood glucose level >150 mg/dL documented in the
medical record but were not diagnosed as having prediabetes or diabetes. Forty-five
(42.5%) of the 106 patients were discharged, 50% (n=53) were admitted, and the rest
(n=8) were transferred to another hospital or a psychiatric unit for admission. O f those
discharged (n=45), only one patient (2.2%) was informed about their elevated blood
glucose level and referred for follow-up.
There is a lack of agreement about what blood glucose value should be used to
indicate further testing is needed to screen for prediabetes. Ginde et al. (2009) used >140
mg/dL for their study to identify possible prediabetics. In an earlier study Ginde et al.
(2008) found random blood glucose levels greater than 120-140 mg/dL were predictive of
elevated HbAlc. Further testing showed just over 1/3 of those who followed up for oral
glucose tolerance testing had diabetes. The inclusion criteria of a blood glucose value
>150 mg/dL used in this study is even higher than the values used in prior studies;
therefore, it is likely even more than 1/3 of the participants in this study could have
prediabetes or diabetes.
Looking at the profiles of patients with pre-diabetes, previous research has
reported demographics, BMI, and history of hypertension. This is the first study to report
rates o f occurrence of blood pressure >130/80, previous blood glucose value >150
mg/dL, and reason for visit. The American Diabetes Association recommends diabetics
maintain a blood pressure < 130/80. For that reason, this value was used to examine this
population of patients. For the group with blood glucose value >150 mg/dL without a
history of diabetes, 49% has a blood pressure >130/80. Further research is needed to see
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if that correlates with those who end up undergoing further testing and test positive for
prediabetes.
No prior studies have used a previous blood glucose value >150 mg/dL to screen
for prediabetes. This number was selected because multiple other glucose values above
and below 150 mg/dL; values as low as 125 and as high as 200 mg/dL had already been
examined through research. Despite multiple studies, there is still not a guideline for ED
providers to use to determine when referral is indicated. Further research is necessary to
evaluate if those who present to the ED with a random blood glucose level >150 mg/dL
without a history o f diabetes get referred. Future research should provide demographics
and risk factors on those referred if they pursue follow up testing and if they are
diagnosed with prediabetes.
Significant relationships were found in this study. Blood glucose level correlated
with BMI (r = .165, p < .05), previous blood glucose value >150 mg/dL (Cramer’s V =
.480, p < .001), age (r = .157, p < .05), and reason for visit (Cramer’s V = .321, p <.01).
Emergency department nurses and providers need to be aware of the significance of these
relationships to help guide them as they care for patients. They show relationships
between risk factors and blood glucose levels. No other studies have shown a significant
correlation between history of previous blood glucose value >150 mg/dL and reason for
visit.
It is not clear why this study did not show a significant correlation between blood
glucose levels and elevated BP >130/80, history of hypertension, race/ethnicity, or
gender, while previous studies cited in the literature have found they increase the risk of
prediabetes and diabetes. Nonetheless, ED nurses and providers should have a heightened
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awareness of patients with an elevated blood glucose level and any of the risk factors
cited in this study or in other studies cited.
Hoerger et al. (2007) completed a study to examine cost effectiveness of
screening patients to identify those with prediabetes. They screened based on BMI and
looked at patients age 45-74. They used these variables because these patients are more
likely to have prediabetes. This is consistent with the findings of this study. This study
indicated a significant relationship between blood glucose level and age (r = .157, p <
.05) and BMI (r = .165, p < .05).
In the study reported here, 32% (62/193) of the patients who had a blood glucose
level documented in the EMR had an elevated random blood glucose >150 mg/dL. This
is important information for ED nurses and providers because it will give them an
increased awareness o f the prevalence. Although the exact blood glucose level that
warrants follow up is not defined in the literature, this study used >150 mg/dL as the
indicator for those in need of informing and referring. Follow-up testing is necessary to
confirm the risk state of prediabetes or to make a diagnosis of type 2 diabetes.
O f concern, is the finding that out of 45 patients discharged from these two EDs
only one (2.2%) was informed about an elevated random blood glucose value and
referred for follow up. There were 44 missed opportunities. Failing to inform and refer
minimizes patients’ abilities to make relevant lifestyle changes to prevent or delay
progression to type 2 diabetes. This finding is significantly lower than those found by
Graffeo (2001), who reported 20% of ED charts with unexplained hyperglycemia >160
mg/dL had documentation about referral.
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Ginde et al. (2009) used >140 mg/dL for their inclusion criteria to assess
retrospective data to evaluate if ED patients were being identified as possible prediabetics
and informed about a plan for follow up. They found 10% were informed and 6% were
referred. Even with a different and lower blood glucose value than that used in this study,
they found a higher rate of informing and referring than was discovered in this study.
A patient may have prediabetes and its adverse micro- and macro-vascular
complications for up to seven years before diabetes is diagnosed (Aroda & Ratner, 2008;
Harris, Klein, Welton, & Knulman, 1992). Early identification and treatment of patients
who may have undiagnosed prediabetes is essential in preventing or delaying progression
to type 2 diabetes (Bergman, 2010; Hsueh et al., 2010).
Screening asymptomatic patients was controversial in the literature, although
recommended by the ADA. This study was not done to encourage screening, but rather
was founded on the idea if a provider has access to an elevated lab value, he or she
should identify the abnormality, inform the patient, and refer them for follow-up. It is an
opportunity not to be missed.
It is highly likely there are patients in this group of 106 who have prediabetes or
diabetes. Often patients have prediabetes but are asymptomatic. With proper informing
and referring, each will have the opportunity to seek follow-up and testing to confirm or
reject their risk.
Many patients use the ED as a primary care setting. All ED patients are
discharged with the name of a physician or clinic to follow up with; however, unless
follow-up is emphasized and encouraged, many do not. If patients are asymptomatic, it is
unlikely they will seek further tests or treatments. Without informing patients about an
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elevated random blood glucose level, explaining what the risks are, and referring them,
they may never have another opportunity to be tested and treated.
Importance to Advancement of Knowledge
This study examined data from patients in two EDs to describe elevated random
blood glucose (>150 mg/dL), BMI, elevated BP, and select demographic characteristics
(age, gender, race/ethnicity) in the ED setting. It also examined the rate at which
discharged ED patients were informed and referred for follow-up. This study will add to
the scientific knowledge by providing data on questions not previously explored.
Findings have the potential to improve ED nurses’ and providers’ awareness about the
rates o f non-diabetic patients with random blood glucose levels >150 mg/dL seen in the
ED. Exploring the current practice in the ED for informing the patient about his or her
elevated blood glucose level and referring him or her for follow-up serves as an indicator
of missed opportunities for patients who are discharged. The study also examined the
relationships between risk factors and elevated blood glucose levels in the ED population.
These relationships are important to guide future intervention development and research.
Conclusion and Implications for Nursing
Pender’s Health Promotion Model was the conceptual framework guiding this
study. It was chosen because as the model suggests, patients will likely respond to the
interpersonal influences o f an ED provider informing and educating them about an
elevated random blood glucose level. When the provider explains the risks involved,
refers the patient for follow up and urges them to follow up for further testing, this will
lead to the patient making a commitment to action. The next step is taking the action, in
which the patient will follow up for further testing. If the patient does, in fact, fit the
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criteria for a prediabetes diagnosis, he or she can make important decisions about lifestyle
modifications for improved health and well-being.
Indeed, research indicates the ED visit may be the only opportunity for some
patients to interact with a health care provider. This makes it an ideal place to identify
patients with possible prediabetes and refer them for follow-up. Emergency departments
need to adopt policies to ensure providers will inform and refer patients with elevated
blood glucose levels for further evaluation and treatment o f the elevated blood glucose
level.
ED patients are given discharge instructions upon discharge that include their
diagnosis and any findings. The provider instructs them to follow-up with a specific
physician or clinic. They are typically notified about abnormal findings that require
follow-up. Emergency nurses must partner with other providers to educate patients with
elevated random blood glucose levels about the risks and complications of prediabetes
and the importance of following up on their results. ED nurses should take an active role
in advocating for informing and referring by ED providers. They should also promote
protocols to enable ED nurses to provide this information. Future studies are needed to
identify the ongoing barriers that prevent providers from informing patients about their
elevated random blood glucose levels and referring them for follow-up.
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